Valeant Turns Assets to Cash With $2.1 Billion in Deals

The video discusses a company's financial strategy, focusing on its $30 billion debt and asset sales worth $2 billion. It highlights the positive investor response to asset sales, including Dendreon and dermatology assets, and the challenges of future debt obligations. The company may need to sell $5 to $15 billion in assets, with potential sales of core businesses like Salix. The discussion includes valuation, bond principles, and term loans, emphasizing the need for strategic asset sales to manage debt effectively.

What is the total debt the company is trying to manage?

• $10 billion

• $30 billion

• $40 billion

• $20 billion

What type of assets is the company selling at favorable valuations?

• Real estate

• Cancer and dermatology assets

• Automobiles

• Technology

When is the company expected to face significant financial stress due to debt?

• 2018

• 2019

• 2020

• 2021

How much in assets does the company plan to sell to manage its debt?

• $15 to $25 billion

• $1 to $5 billion

• $25 to $35 billion

• $5 to $15 billion

What was the outcome of the company's attempt to sell its core Salix business?

• It was sold for $5 billion

• The sale fell apart

• The sale was postponed

• It was sold successfully